Molly Waldron
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
-
- Cardiac Ischemia and Reperfusion
Papers in
-
- Advanced Glycation End Products research 1
-
- Occupational Health and Performance 1
- Co-authors
- Mingzhan Xue (1 shared paper)Ngianga‐Bakwin Kandala (1 shared paper)Mark I. Fowler (1 shared paper)Alaa Shafie (1 shared paper)Attia Anwar (1 shared paper)Martin O. Weickert (1 shared paper)Gail Jenkins (1 shared paper)David J. Messenger (1 shared paper)
- Journals
- The Lancet (1 paper)Diabetes (1 paper)European Journal of Epidemiology (1 paper)BMC Cardiovascular Disorders (1 paper)Rheumatology Advances in Practice (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Molly Waldron
4 papers receiving 460 citations
Molly Waldron's Hit Papers
Peers
Comparison fields: 5 of 34
- Clinical Biochemistry 106
- Pathology and Forensic Medicine 155
- Geriatrics and Gerontology 11
- Aging 2
- Cardiology and Cardiovascular Medicine 29
Countries citing papers authored by Molly Waldron
This map shows the geographic impact of Molly Waldron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Waldron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Waldron more than expected).
Fields of papers citing papers by Molly Waldron
This network shows the impact of papers produced by Molly Waldron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Waldron. The network helps show where Molly Waldron may publish in the future.
Co-authors
The 10 scholars most cited alongside Molly Waldron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 269 |
| 2 | 2016 | 188 | |
| 3 | 2025 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2025 | 0 |
About Molly Waldron
Molly Waldron is a scholar working on Clinical Biochemistry, Occupational Therapy, Pathology and Forensic Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 5 papers that have together received 462 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (1 paper), Cardiac Ischemia and Reperfusion (1 paper) and Occupational Health and Performance (1 paper). The work is most often cited by research in Clinical Biochemistry (106 citations), Pathology and Forensic Medicine (155 citations), Geriatrics and Gerontology (11 citations), Aging (2 citations) and Cardiology and Cardiovascular Medicine (29 citations). Molly Waldron has collaborated with scholars based in United Kingdom. Frequent co-authors include Mingzhan Xue, Ngianga‐Bakwin Kandala, Mark I. Fowler, Alaa Shafie, Attia Anwar, Martin O. Weickert, Gail Jenkins, David J. Messenger, Paul John Thornalley and Naila Rabbani. Their work appears in journals such as The Lancet, Diabetes, European Journal of Epidemiology, BMC Cardiovascular Disorders and Rheumatology Advances in Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.